Corporate Positive

IMUNON Hosts R&D Day Highlighting Progress on OVATION 3 Study in Pursuit of First Frontline Immunotherapy for Advanced Ovarian Cancer

Breaking news from global financial markets

il y a 2 semaines
Lire Plus
Start of Day Message
il y a 2 semaines 1,356